SCHEDULE 13G: RTW Investments and Dr. Roderick Wong Disclose 8.3% Passive Stake in Verastem, Inc.

RTW Investments, LP and its Managing Partner, Roderick Wong, M.D., have disclosed a passive beneficial ownership of 8.3% in Verastem, Inc.'s common stock as of March 31, 2025.

Summary

• RTW Investments, LP and Roderick Wong, M.D. (collectively, the "Reporting Persons") have filed a Schedule 13G indicating beneficial ownership in Verastem, Inc.
• As of March 31, 2025, the Reporting Persons collectively beneficially own 4,245,476 shares of Verastem, Inc. common stock.
• This ownership represents 8.3% of Verastem, Inc.'s outstanding common stock.
• The percentage is calculated based on 51,489,998 shares outstanding as of March 25, 2025, as reported in the Company's Definitive Proxy Statement on Schedule 14A.
• The filing indicates a passive investment, stating that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: Neutral, as this is a factual disclosure of beneficial ownership without any performance or strategic updates.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of a significant passive investment by an institutional investor in a publicly traded company, common in the biotechnology or pharmaceutical sector where specialized funds often take stakes in promising firms. It does not provide specific industry trends or competitive analysis.

Stakeholder Impact

• This filing primarily impacts shareholders by disclosing a significant passive ownership stake by an institutional investor, which can be viewed as a vote of confidence or simply a portfolio allocation decision.

Key Dates

Keywords

Verastem Inc, RTW Investments, Roderick Wong, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Investor, Biotechnology, Pharmaceuticals